The global bone cement and accessories market includes sales of bone cement, cement mixer/delivery (CDM) systems, and cement spacer molds. Sales of bone cement and accessories are directly correlated to annual hip, knee, shoulder, elbow, digit, ankle, and wrist arthroplasty procedure volumes. Globally, individuals over the age of 65 are expanding rapidly as a proportion of the total population. This trend will drive growth in the number of joint replacements performed because conditions such as osteoarthritis develop with age and will require treatment with cemented implants. Surgeon adoption of joint revision and hip resurfacing implants will further fuel procedural demand and consequently sales of bone cement and accessories. Additionally, new technologies such as cement spacer molds will be increasingly adopted because these devices can preserve normal leg length, allow for early patient mobilization, and quickly deliver the antibiotics locally to the periprosthetic space to prevent further infection. Although cost-containment efforts in medical facilities will impose downward pressure on device average selling prices (ASPs), the rising penetration of premium-priced devices, such as antibiotic bone cement, cement gun cartridges, and vacuum mixing systems, will promote increases in aggregate device ASPs and thereby promote revenue expansion. Additionally, the continued adoption of cementless implants, which wear down less quickly than cemented implants and do not require bone cement, will restrict the bone cement and accessories market. Overall, the global bone cement and accessories market will expand steadily over from 2008 to 2013.
Questions Answered in This Report:
* The global recession that persisted through 2009 caused growth in hip, knee, and small-joint reconstructive implant procedures to slow. How did this dip in procedure growth impact sales of bone cement, CDM systems, and cement spacer molds? How quickly are these markets expected to recover? What geographic markets were most impacted by slowed elective joint-reconstruction procedures?
* Antibiotic bone cement is penetrating the global bone cement market at the expense of nonantibiotic bone cement. What is driving the uptake of antibiotic bone cement? Why are US orthopedic surgeons less inclined to use antibiotic bone cement than their European counterparts? How does this compare with surgeon preference in Japan and the emerging markets?
* Cost-cutting measures by hospitals and device purchasers are impeding aggregate device ASP growth, particularly in Europe. How will these cost-cutting measures impact the penetration of premium-priced devices, such as antibiotic bone cement, cement gun cartridges, and vacuum mixing systems? How will these ASP trends compare to the US, Japan, and the emerging markets?
* Cement spacer molds are rapidly emerging as a new segment of the global bone cement market. What factors are fueling cement spacer mold revenue growth? Why is the US market for these devices much larger than those of Europe, Japan, Brazil, India, and China?
Regions covered: US, Europe (France, Germany, Italy, and the UK), Japan, and Emerging Countries (Brazil, India, and China)
Segmentation: Our analysis of each country uses the following segmentation:
- Bone cement
- CDM systems
- Cement gun cartridges
- Enclosed vacuum mixers
- Manual mixing systems
- Cement spacer molds
Market forecast features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 7-year period (2007–2013).
Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.